Computed tomography radiomics combined with clinical parameters for hepatocellular carcinoma differentiation: a machine learning investigation.

PURPOSE

To evaluate the performance of a combined clinical-radiomics model using multiple machine learning approaches for predicting pathological differentiation in hepatocellular carcinoma (HCC).

MATERIAL AND METHODS

A total of 196 patients with pathologically confirmed HCC, who underwent preoperative computed tomography (CT) were retrospectively enrolled (training: = 156; validation: = 40). The modelling process included the folowing: (1) clinical model construction through logistic regression analysis of risk factors; (2) radiomics model development by comparing 6 machine learning classifiers; and (3) integration of optimal clinical and radiomic features into a combined model. Model performance was assessed using the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). A nomogram was constructed for clinical implementation.

RESULTS

Two clinical risk factors (BMI and CA153) were identified as independent predictors of differentiated HCC. The clinical model showed moderate performance (AUC: training = 0.705, validation = 0.658). The radiomics model demonstrated improved prediction capability (AUC: training = 0.840, validation = 0.716). The combined model achieved the best performance in differentiating HCC pathological grades (AUC: training = 0.878, validation = 0.747).

CONCLUSIONS

The integration of CT radiomics features with clinical parameters through machine learning provides a promising non-invasive approach for predicting HCC pathological differentiation. This combined model could serve as a valuable tool for preoperative treatment planning.